Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3555 SEK | +19.30% | +28.80% | -96.44% |
05-22 | Xbrane Successfully Scale Up Xdivane- Biosimilar Candidate to Opdivo®? | CI |
05-16 | Transcript : Xbrane Biopharma AB, Q1 2024 Earnings Call, May 16, 2024 |